Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

Patients treated with darolutamide who reached ultra-low PSA at any time had lower risk of radiological progression or death versus those with PSA >=0.2 ng/mL, with a risk reduction of 91%, as did ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to an advanced prostate cancer podium session. Dr. Alejandro Sanchez presented the results ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for ...

There are several organizations that have issued guidelines for PSA testing. The American Urological Association (AUA) recommends PSA screening: annually for those at high-risk starting at ages 40 ...

Mohammad Mahmoud, MD, looks ahead to the 2025 American Urological Association (AUA) meeting in Las Vegas, which will feature a robust program on metastatic prostate cancer centering on new ...

The RNA study identified a panel of transcripts that when combined with age and PSA resulted in an AUC of 0.827. Similarly, using a proprietary method for analyzing DNA methylation combined with ...

Jason M. Hafron, MD, discusses IsoPSA, a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are ...

“With these critical advancements, we are eager to connect, collaborate, and drive meaningful discussions with the urology community at AUA 2025, shaping the future of bladder and prostate ...

In a large multi-center study, researchers demonstrated that cell free RNA expression and DNA methylation biomarkers in seminal fluid can differentiate clinically significant prostate cancer (Grade ...